| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 530 | $130 | $69.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 890 | $60 | $49K |
| J9155 | Injection, degarelix, 1 mg | 15,040 | $1 | $45.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 420 | $80 | $33.4K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 350 | $20 | $7.3K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 60 | $70 | $4.2K |
| 51798 | Providers perform this ultrasound to measure the volume of residual urine in the bladder. | 490 | $10 | $3.9K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 30 | $110 | $3.4K |
| J9030 | BCG live intravesical instillation, 1 mg | 1,450 | $1 | $2.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 30 | $100 | $2.9K |